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1. Introduction
  Diabetes mellitus is a chronic metabolic disorder 
caused by an absolute or relative lack of insulin and/or 
reduced insulin activity which results in hyperglycemia 
and abnormalities in carbohydrate, fat and protein 
metabolism[1,2]. Management of diabetes without any side 
effects is still a challenge for medical system. This leads 
to an increasing search for improved antidiabetic drugs. 
Few of plant treatments used in traditional medicine 
for diabetes received scientific scrutiny and WHO has 
recommended that this area warrants attention[3].  Acacia 
arabica (Momosaceae); Benincasa hispida (Cucurbitaceae); 
Tinisporia cordifolia   (Menispermaceae); Jatropa curcas 
(Euphorbiaceae) and Ocimum sanctum Linn are traditionally 
used for treatment of diabetes[4]. Acacia arabica possesses 
antibacterial[5], antiviral[6] and antifertility activities[7]. 
Tinospora cordifolia was reported to have adaptogenic[8], 
antiviral[9], antihyperglycemic[10], immunomodulatory[11], 
antineoplastic[12], cardioprotective[13] and antioxidants[14,15], 
activities. Ocimum sanctum  showed antioxidant, 
antifungal[16], antimicrobial[17] and wound healing[18] 
activities. Jatropha curcus possesses anti-diabetic[19], 
wound-healing[20], antitumor[21], anti-inflammatory[22] and 
antifungal[23] activities. Benincasa hispida was reported to 
have antinociceptive, anti-pyretic[24] and anti-stress[25] 
activities. The objective of present study was to evaluate 
antidiabetic activity of chloroform extracts of Acacia arabica 
bark, Benincasa hispida fruit, Tinispora cordifolia stem, 
Ocimum sanctum areal parts and Jatropha curcus leaves.
2. Material and methods
2.1. Plant material 
  The bark of Acacia arabica, fruit of Benincasa hispida, 
stem of Tinospora cordifolia, aerial part of Ocimum 
sanctum and leaves of Jatropha curcus were collected 
from Pune District, Maharashtra, India in August 2008. 
The plants were identified and authenticated by Dr. R. 
B. Deshmukh, Department of Botany, Sharadabai Pawar 
College, Malegaon(bk) Tal- Baramati Dist- Pune.(India). 
The voucher specimens (AA-08, BH-08, TC-08, OS-08 and 
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JC-08 respectively) are deposited in herbarium. The samples 
were cleaned, dried in shade and powdered. The powdered 
samples were kept in airtight container for further studies. 
2.2. Chemicals and drugs 
  Alloxan monohydrate, tolbutamide and chloroform were 
purchased from Sigma Chemicals, St. Louis. Chemical kits 
for estimation of blood glucose, cholesterol, triglyceride, LDL 
and HDL were purchased from Erba Diagnostics, Mannheim.
2.3. Animals
  The male albino rats (Wistar strain weighing 150-180 g) and 
albino mice ( weighing 20-30 g) were procured from SVPM’s 
College of Pharmacy, Malegaon (bk), Tal- Baramati Dist- 
Pune, India and housed in animal house. They were kept 
at 27依3 曟 (Relative humidity: 65%依10% and light / dark 
cycle for 12 h. All the animals were fed with rodent pellet 
diet (Gold Mohr, Lipton India Ltd.) and water was allowed 
ad-libitum under strict hygienic conditions. Institutional 
Animal Ethics Committee (IAEC) approved all the protocol 
of study (Reg. No. 1214/ac/08/CPCSEA).
2.4. Preparation of extract 
  Dried powders each of 100 g of Acacia arabica bark 
(CEAA), Benincasa hispida fruit (CEBH), Tinospora cordifolia 
stem (CEOS), Ocimum sanctum aerial part and leaves of 
Jatropha curcus (CETC) were extracted with chloroform by 
Soxhlet extraction and solvents were evaporated by rotary 
evaporator. Concentrated extracts were dried on water bath 
at controlled temperature to yield CEAA 12.30%w/w, CEBH 
14.08%w/w, CETC 9.69%w/w, CEOS 15.07%w/w and CEJC 
11.31%w/w respectively. 
2.5. Toxicity studies
  An acute toxicity of CEAA, CEBH, CETC, CEOS and CEJC 
were carried out in female albino mice (25-30 g). The mice 
were divided in to six groups (n=6). The animals were fasted 
for overnight prior to the experimentation. The fixed dose 
method of CPCSEA (Mrs. Prema Veeraraghavan. Expert 
consultant, CPCSEA, OECD guide line No. 420; Oct 2000) was 
adopted for toxicity studies. 
2.6. Preparation of diabetic rats
  Alloxan monohydrate dissolved in saline was injected in 
rats intraperitoneally at dose of 150 mg/ kg body weight. 
After a fortnight, rats with marked hyperglycemia were 
selected and used for the study.
2.7. Experimental design
  The rats were divided into thirteen groups (n=5). Group 
I (controlled group) administered 0.5 mL saline, Group II 
(untreated diabetic rats), group III (diabetic rats receiving 
tolbutamide orally at 80 mg/kg body weight in saline), 
Groups IV to XIII (diabetic rat treated with CEAA, CEBH, 
CETC, CEOS and CEJC at dose of 250 and 500/mg kg body 
weight). Tolbutamide was used as the standard antidiabetic 
throughout the experimentation. The animals were carefully 
monitored at every day. Animals described as fasted were 
deprived of food for at least 12 h but allowed to free access 
for drinking water. Fasting blood glucose measurement was 
done on day 0, 7th and 14th of the study. Blood samples 
were collected by retro orbital method at weekly intervals 
till the end of study and processed for estimation of serum 
glucose and serum lipid[26, 27, 28].
2.8. Biochemical estimation
  Serum samples from all the experimental rats were 
collected for estimation of biochemical parameters, serum 
glucose (GOD-POD method), cholesterol (CHOD-PAP 
method), triglycerides (GPO-Triender method), HDL and 
LDL[29].
2.9. Statistics   
  All values are expressed as Mean 依 SEM. The differences 
were compared using one way analysis of variance (ANOVA) 
followed by Tukey’s multiple comparison tests. P values < 
0.05 were considered as significant.
3. Result
  In untreated diabetic rats, glucose, cholesterol, 
triglycerides, LDL values were elevated to high level during 
the study where as HDL value was decreased. Chronic 
treatment with CEAA, CEBH, CETC, CEOS and CEJC at 250 
and 500 mg/kg significantly (P<0.0001) causes decrease in 
serum glucose on 7th and 14th day as shown in Figure 1, 2 
and 3. Serum cholesterol triglycerides HDL and LDL levels 
also reversed with treatment of test extracts and standard as 
shown in table 1. 
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Figure 1. Effect of CEAA, CEBH, CETC, CEOS and CEJC on serum 
glucose level in diabetic rats on 0 day. 
All values are expressed as Mean 依 SEM (n=5). Statistical comparisons 
between each treatment and untreated diabetic were carried out by 
one way ANOVA followed by Tukey’s multiple comparison tests. *** 
P < 0.0001 when compare to untreated diabetic group.
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Figure 2. Effect of CEAA, CEBH, CETC, CEOS and CEJC on serum 
glucose level in diabetic rats on 7th day. 
All values are expressed as Mean 依 SEM (n=5). Statistical comparisons 
between each treatment and untreated diabetic were carried out by 
one way ANOVA followed by Tukey’s multiple comparison tests. *** 
P < 0.0001 when compare to untreated diabetic group.
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Figure 3. Effect of CEAA, CEBH, CETC, CEOS and CEJC on serum 
glucose level in diabetic rats on 14th day.
 All values are mean 依 SEM (n=5). Statistical comparisons between 
each treatment and untreated diabetic were carried out by one way 
ANOVA followed by Tukey’s multiple comparison tests. *** P < 
0.0001 when compare to untreated diabetic group.
4. Discussion
  Alloxan induces diabetes by damaging the insulin 
secreting cells of pancreas leading to hyperglycemia[30]. 
Diabetes mellitus is a group of syndromes characterized by 
hypoglycemia, altered metabolism of lipids, carbohydrates 
and proteins. It is an increased risk of complications from 
vascular diseases[31].
  An observation in this study correlates with the previous 
research finding, in that the blood glucose levels 
significantly increased in alloxan induced untreated 
diabetic rats. In the present study, the continuous treatment 
of different test compounds for a period of two weeks caused 
a significant decrease in blood glucose of treated diabetic 
rats. These results have confirmed the earlier results of 
our preliminary studies[32]. We have also observed an 
increase in concentration of cholesterol, triglyceride, LDL 
and decrease in HDL in alloxan untreated diabetic rats. 
Hyperlipidaemia is recognized consequence of diabetes 
mellitus[33-35]. Chronic administration of different tests 
extracts normalized serum lipid profile i.e. secondary 
to diabetic state. Diabetes induced hyper lipidaemia is 
attributable to excess mobilization of fat from adipose due 
to the under utilization of glucose[36]. The regression of the 
diabetic state due to chronic administration of different test 
extract at different doses increased the utilization of glucose, 
thereby depressing the mobilization of fat. 
  In conclusion, the present investigation supports the 
hypoglycemic effects of extracts of ethnic folk medicine 
which mitigates pathological states like diabetes mellitus. 
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Table 1
Comparative effect of CEAA, CEBH, CETC, CEOS and CEJC on serum cholesterol, triglycerides, HDL and LDL (mg/dl) in diabetic rats
Groups Treatment
Average serum lipid profile (mg/dL)
Total cholesterol Triglycerides HDL cholesterol LDL cholesterol
I Normal 64.28依3.51   79.64依3.12 48.60 依3.72    48.53依 4.36
II Diabetic 95.28依4.01  143.88依3.52 26.14 依5.61 108.23依7.59
III Diabetic + Tolbutamide 80 mg/ kg     58.78依3.61***      81.10依4.00***    41.86 依 5.94**      55.34依5.46**
IV Diabetic+CEAA 250 mg/kg      72.46依2.69 ***     109.60依3.06***  30.14依4.18       81.34依2.30***
V Diabetic+CEAA 500 mg/kg      61.39依2.06 ***      97.59依2.33***  35.24依4.84       65.71依0.60***
VI Diabetic+CEBH 250 mg/kg     72.01依2.21 ***    109.56依1.23***  31.16依5.14      86.73依1.58**
VII Diabetic+CEBH 500 mg/kg      64.69依1.08 ***      87.41依2.95***  39.30依4.19    63.24依1.60***
VIII Diabetic+CETC  250mg/kg  79.43依3.07*     100.79依2.82***  30.18依3.51   89.24依2.60**
IX Diabetic+CETC  500mg/kg      66.82依1.62 ***      82.91依2.70***  36.13依3.24    71.10依0.60***
X Diabetic+CEOS 250mg/kg    80.23依2.65 *      92.80依1.18***  31.24依4.14    91.46依1.69*
XI Diabetic+CEOS 500mg/kg      65.26依2.71 ***      83.47依2.91***  37.62依3.31       64.18依0.50*** 
XII Diabetic+CEJC 250mg/kg    81.52依2.69 *       87.06依2.02***  29.92依4.12   93.24依1.65
XIII Diabetic+CEJC 500mg/kg      72.18依3.01 ***       95.48依3.74***  38.81依5.21       72.09依1.90***
Values are expressed as Mean 依SEM; (n = 5), a P < 0.05, b p < 0.01, c P<0.001 compared with untreated diabetic rats.
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